Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
TLDR
The expanding role of intravenous nitroglycerin (GTN) in the management of critically ill hospitalized patients demands a clear knowledge of its pharmacodynamics and kinetics in both normal and diseased states, and this study established the relationship between blood levels of GTN and its physiologic effects during and after an i.v. infusion.Abstract:
SUMMARYThe expanding role of intravenous nitroglycerin (GTN) in the management of critically ill hospitalized patients demands a clear knowledge of its pharmacodynamics and kinetics in both normal and diseased states. Accordingly, we studied 16 patients with congestive cardiac failure to establish the relationship between blood levels of GTN and its physiologic effects during and after an i.v. infusion. The end point of this study was either a greater than 25% fall in pulmonary capillary wedge presure or more than a tenfold increment over the initial GTN infusion rate. Infusion rate of GTN and blood concentration correlated well (r = 0.75, p < 0.001). Patients were divided into two groups based on their blood GTN concentration. Group I patients (n = 8) achieved blood GTN concentrations of 1.2-11.1 ng/ml and all reached the hemodynamic end point. The minimum effective blood GTN concentration was 1.2 ng/ml at an infusion rate of 15 μg/min. Group 2 patients (n = 8) had blood levels greater than 11.1 ng/ml and only three achieved the hemodynamic end point. Group 2 had greater systemic venous congestion than group 1 (right atrial pressure 19 ± 4 mm Hg (SD) vs 10 ± 4 mm Hg [p < 0.0011). In addition, group 2 had lower total body clearance of GTN (3.6 ± 1.8 1/min) than group 1 (13.8 ± 5.8 1/min) (p < 0.005). The low clearance of GTN in group 2 patients may be explained in part by impaired hepatic metabolism secondary to severe systemic venous congestion. Complete blood GTN data were available on five patients after cessation of the GTN infusion and revealed a short half-life of 1.9 minutes. Some patients failed to reach the hemodynamic end point with high infusion rates of GTN (220-4 μg/min), and blood levels of 42.2-481.3 ng/ml. There was no evidence of toxicity despite these high GTN blood levels.read more
Citations
More filters
Journal ArticleDOI
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.
Stuart D. Katz,Luigi M. Biasucci,Carlo Sabba,Joel A. Strom,Guillaume Jondeau,Marie Galvao,Steven B. Solomon,Srdjan D. Nikolic,Robert Forman,Thierry H. LeJemtel +9 more
TL;DR: In this paper, the local vascular response to intraarterial infusions of graded concentrations of acetylcholine and nitroglycerin was studied in the superficial femoral artery of 19 patients with congestive heart failure (New York Heart Association classes I to IV) and 6 age-matched normal control subjects.
Journal ArticleDOI
Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans
R F Wilson,C W White +1 more
TL;DR: This study used a subselective coronary Doppler catheter to measure the dose-response kinetics of a shorter acting vasodilator, intracoronary papaverine, and found that at maximal hyperemia, mean arterial blood pressure fell 9 +/- 2% after intracornary papaversine, 8 +/- 4% after dipyridamole, and 3 +/- 3% after meglumine diatrizoate.
Journal ArticleDOI
Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.
Kensuke Egashira,Tetsuzi Inou,Yoshitaka Hirooka,Akira Yamada,Y. Maruoka,Hisashi Kai,Masaru Sugimachi,Satoshi O. Suzuki,A. Takeshita +8 more
TL;DR: Mild atherosclerotic lesions in the study artery and coronary risk factors are accompanied by impaired endothelium-dependent dilation of coronary resistance arteries evoked with ACH, which may result in altered regulation of myocardial perfusion in patients with mild coronary atherosclerosis and coronaryrisk factors.
Journal ArticleDOI
Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure
TL;DR: The hypothesis that neurohormonal activation and depletion of sulfhydryl groups may interact to cause the loss of hemodynamic efficacy that occurs during prolonged treatment with intravenous nitroglycerin in patients with heart failure is supported.
Journal ArticleDOI
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
TL;DR: In this paper, the acute and long-term effects of isosorbide dinitrate on clinical status and on resting and exercise hemodynamics were investigated in 30 patients with moderate-to-severe congestive heart failure in a double-blind, randomized, placebo-controlled trial.
References
More filters
Journal Article
Mechanism of tolerance development to organic nitrates
TL;DR: It is proposed that organic nitrate tolerance involves the oxidation of a critical sulfhydryl in the glyceryl trinitrate "receptor" and this hypothesis is supported by the reversal of both in vitro - and in vivo -induced glycery ltrinitrate tolerance by the disulfide reducing agent, dithiothreitol.
Journal ArticleDOI
Thermodilution cardiac output determination with a single flow-directed catheter.
James S. Forrester,William Ganz,George A. Diamond,Thomas J. McHugh,David W. Chonette,H.J.C. Swan +5 more
TL;DR: A single right heart catheter which allows simultaneous determinations of cardiac output, pulmonary artery pressure, pulmonary capillary wedge pressure, and right atrial pressure in critically ill patients is described.
Journal ArticleDOI
Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure.
TL;DR: In patients in whom the cardiac reserve is diminished, the normal increase of cardiac output during exercise is attenuated, or even abolished, and Diminished activity of this important reserve mechanism could be a factor in the abnormal cardiac activity.
Journal ArticleDOI
Drug therapy. Clinical Pharmacokinetics (first of two parts).
David J. Greenblatt,Kock-Weser J +1 more
Journal ArticleDOI
Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
TL;DR: The renin-angiotensin system appears to have an important role in the elevated SVR in some patients with heart failure, and chronic inhibition of converting enzyme should be explored as a possible therapeutic approach.